Business

OTC Application

Valereum Plc has reapplied to the OTC Markets Group for its ordinary shares to be cross-traded on the OTCQB Market in the United States, a move intended to enhance visibility and accessibility for North American investors and support its strategy for a potential NASDAQ or NYSE listing. This application follows the divestment of a majority stake in London BTC Company Limited, which removed a regulatory constraint under the Investment Company Act of 1940. The company views this as further evidence of its strategic repositioning, alongside the establishment of the Valereum QGP-SP vehicle and the planned USD $200 million Royalty & Streaming financing. Disclaimer*

articleValereum PlcDecember 4, 20253/company/valereum-plc/news/otc-application-1
OTC Application

About this update from Valereum Plc

[{"type":"text","content":"\n\n04/12/25\nValereum Plc\n(\"Valereum\", \"VLRM\" or the \"Company\")\nApplication to Cross-trade on the OTCQB Market\nValereum Plc (AQSE: VLRM) is pleased to announce that it has re-applied to the OTC Markets Group for its Ordinary Shares to be cross traded publicly on the OTCQB Market in the United States (the \"Cross-trade\"). Subject to the approval of OTC Markets Group and the satisfaction of customary conditions.\nA successful Cross-trade on to the OTCQB Market will enable Valereum's shares to be traded in US dollars through a wide range of US brokers, providing North American investors with easier access. This increased visibility and accessibility is an integral component of Valereum's broader US capital-markets strategy, which includes the previously announced intention to progress towards a potential listing on either NASDAQ or the New York Stock Exchange. Strengthening the Company's presence within the United States is an important step in enhancing market reach, broadening the shareholder base, and supporting long-term liquidity.\nThe application follows the completion of Valereum's divestment of the majority of its stake in London BTC Company Limited. This strategic divestment removes a regulatory constraint that had previously prevented the Company from qualifying for an OTCQB Cross-trade under the Investment Company Act of 1940. Clearing this barrier facilitates access to a broader set of international capital pools.\nThe Board views the submission of the OTCQB application as further evidence of the momentum behind Valereum's strategic repositioning. Alongside the establishment of the Valereum QGP-SP vehicle and the continued advancement of the planned USD $200m Royalty & Streaming financing, the move towards the OTCQB Market reflects the Company's vision for long-term growth.\nThe Company intends to update the market as the Cross-trade application progresses and on any material developments related to its US capital-markets strategy.\nFor further information, please contact:\n\n\n\n\nValereum Plc\nKarl Moss\n\n\n \nTel: +44 7938 767319 \nInvestor Hub\n\n\n\n\nFortified Securities\nGuy Wheatley\n                         \n\n\n \nTel: +44 203 4117773   &nbs...

More updates from Valereum Plc